Pulsed field ablation in cavotricuspid isthmus does not induce significant neointimal hyperplasia - results from prospective angiography assessment

Abstract Introduction The efficacy and safety of pulmonary vein isolation (PVI) using pulsed field ablation (PFA) have been well demonstrated (1). However, concerns have been raised regarding the use of the PFA in the proximity of the coronary arteries, specifically about potential acute (spasm) and chronic arterial wall changes (neointimal hyperplasia) (2). Purpose This study investigated the safety of PFA during CTI ablation, with a specific focus on chronic coronary lesion assessment through computed tomography (CT) angiography at 3 months after the index procedure. The primary outcome was a composite measure that included the occurrence of coronary spasm during ablation or a reduction in the cross-sectional area of the distal right coronary artery (RCA), as observed on CT angiography follow up. Methods Patient population consisted of subjects enrolled under the 3 different first in human studies with PFA platforms. All study protocols included mandatory CT angiography before and 3 months after the index ablation procedure. Focal (Faraflex large focal platform and PFA through commercially available solid tip, force-sensing catheters with CENTAURI generator), as well as multipolar (Arga Medtech) PFA platforms were used. CTI ablation and bidirectional CTI block check were performed in accordance with a standard clinical practice. Only a multipolar subset of patients received bolus of nitroglycerin intravenously prior to the first PFA application. A continuous twelve-lead ECG monitoring was used to track ST-segment changes. Baseline and three months post-procedure CT angiography (per CT coronary angiography protocol) were conducted to assess distal RCA changes. Significant neointimal hyperplasia was defined as a decrease of more than 50% in the cross-sectional area of the distal part of RCA. Results A total of 24 patients were included (age 64 [standard deviation (SD) 7] years; ejection fraction 60% [SD 6%]; left atrial size 45 [SD 4] mm). Of these, 14 patients were in the focal PFA group (Faraflex 7, CENTAURI 7) and 10 were in the multipolar group. Acute bidirectional conduction block of CTI was achieved in all patients. There was one clinicaly overt case of coronary spasm with ST elevation in the focal group, which resolved after an intravenous nitroglycerin injection. Significant neointimal hyperplasia in the distal part of the RCA was not observed in any of the subjcts at 3 months CT angiography follow up. Conclusion Neointimal hyperplasia at 3 months post PFA in CTI was not observed in the subject teated with differente PFA platforms/waveform configurations. Safety profile of CTI ablation with the PFA platforms observed in our study should be further validated in larger patient cohorts.

Authors

Publication Details

Journal
EP Europace
Published
2025-05-01
DOI
https://doi.org/10.1093/europace/euaf085.458
Primary Topic
Cardiac Arrhythmias and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulsed field ablation in cavotricuspid isthmus does not induce significant neointimal hyperplasia - results from prospective angiography assessment

I Sikiric, Goran Dujić, Toni Brešković, Zrinka Jurišić et al.
EP Europace
Cardiac Arrhythmias and Treatments
article

Pulsed field ablation in cavotricuspid isthmus does not induce significant neointimal hyperplasia - results from prospective angiography assessment

I Sikiric, Goran Dujić, Toni Brešković, Zrinka Jurišić, Ante Anić, Josip A. Borovac, Josip Katić, Marija Dagelić, Ivan Aranza
article en

Abstract

Abstract Introduction The efficacy and safety of pulmonary vein isolation (PVI) using pulsed field ablation (PFA) have been well demonstrated (1). However, concerns have been raised regarding the use of the PFA in the proximity of the coronary arteries, specifically about potential acute (spasm) and chronic arterial wall changes (neointimal hyperplasia) (2). Purpose This study investigated the safety of PFA during CTI ablation, with a specific focus on chronic coronary lesion assessment through computed tomography (CT) angiography at 3 months after the index procedure. The primary outcome was a composite measure that included the occurrence of coronary spasm during ablation or a reduction in the cross-sectional area of the distal right coronary artery (RCA), as observed on CT angiography follow up. Methods Patient population consisted of subjects enrolled under the 3 different first in human studies with PFA platforms. All study protocols included mandatory CT angiography before and 3 months after the index ablation procedure. Focal (Faraflex large focal platform and PFA through commercially available solid tip, force-sensing catheters with CENTAURI generator), as well as multipolar (Arga Medtech) PFA platforms were used. CTI ablation and bidirectional CTI block check were performed in accordance with a standard clinical practice. Only a multipolar subset of patients received bolus of nitroglycerin intravenously prior to the first PFA application. A continuous twelve-lead ECG monitoring was used to track ST-segment changes. Baseline and three months post-procedure CT angiography (per CT coronary angiography protocol) were conducted to assess distal RCA changes. Significant neointimal hyperplasia was defined as a decrease of more than 50% in the cross-sectional area of the distal part of RCA. Results A total of 24 patients were included (age 64 [standard deviation (SD) 7] years; ejection fraction 60% [SD 6%]; left atrial size 45 [SD 4] mm). Of these, 14 patients were in the focal PFA group (Faraflex 7, CENTAURI 7) and 10 were in the multipolar group. Acute bidirectional conduction block of CTI was achieved in all patients. There was one clinicaly overt case of coronary spasm with ST elevation in the focal group, which resolved after an intravenous nitroglycerin injection. Significant neointimal hyperplasia in the distal part of the RCA was not observed in any of the subjcts at 3 months CT angiography follow up. Conclusion Neointimal hyperplasia at 3 months post PFA in CTI was not observed in the subject teated with differente PFA platforms/waveform configurations. Safety profile of CTI ablation with the PFA platforms observed in our study should be further validated in larger patient cohorts.

EP EuropaceVol. 27(Supplement_1)
Openalex Percentile: Top 79%
Cardiac Arrhythmias and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.